




























Background: Continuous renal replacement therapy (CRRT)-requiring acute kidney injury (AKI) in critically ill adult 
patients frequently occurs in the intensive care unit and is associated with high morbidity and mortality. There is a 
paucity of epidemiological data regarding CRRT-requiring AKI in sub-Saharan Africa. 
Methods: We conducted a retrospective cohort study of all critically ill adult patients with CRRT-requiring AKI at 
Universitas Academic Hospital, Bloemfontein, during the period 1 July 2010 to 30 June 2014. The primary purpose 
was to determine the incidence of CRRT-requiring AKI. Secondary objectives were to record mortality, renal 
recovery and duration of CRRT.
Results: The number of patients with CRRT-requiring AKI was 87 (1.1%) of the 7 709 patients admitted to the ICU 
over this 4-year period. Of these, 37 (43%) were HIV infected. The median age was 56 years (43 years in the HIV-
infected versus 64 years in the HIV-uninfected group (P < 0.01). The majority of the HIV-infected patients were  
Black (89%). Metabolic acidosis together with pulmonary oedema and oliguria were the main indications for dialysis. 
The overall mortality was 31% with most of the deaths (82%) occurring in the HIV-positive patients. These patients 
had a mortality rate of 60% versus 10% among the uninfected (P < 0.01. Multivariate logistic regression identified 
female sex and HIV infection as independent predictors of mortality. The median duration of CRRT was 3 days and 
renal recovery occurred in 26% of patients.
Conclusions: The incidence of CRRT-requiring AKI in critically ill adult patients at Universitas Academic Hospital 
was low. The overall mortality was relatively low when compared to that reported by others; however, it was 
relatively very high in the HIV-infected group.
Keywords: Acute kidney injury; continuous renal replacement therapy; critically ill adults, South Africa.
ORIGINAL ARTICLE
Outcomes of critically ill adult patients with continuous 
renal replacement therapy-requiring acute kidney injury in 
the Free state province of south Africa: the impact of HIV
Seydou Nourou Camara1, Mogamat-Yazied Chothia2 
1Department of Critical Care, Universitas Academic Hospital, Bloemfontein, South Africa; 2Divisions of General Medicine and Nephrology, 
Department of Medicine, Tygerberg Hospital and Stellenbosch University, Cape Town, South Africa.
Received 31 January 2017; accepted 13 May 2017; published 21 June 2017.
Correspondence: Dr M-Y Chothia, yaziedc@sun.ac.za.
© The Author(s) 2017. Published under a Creative Commons Attribution 4.0 International License.
African Journal of Nephrology 
Official publication of the African Association of Nephrology 
Volume 20, No 1, 2017, 39-44
INtrODUctION
Continuous renal replacement therapy (CRRT) was 
introduced into the intensive care (ICU) setting as early 
as the 1980s [1]. This was due to the need for effective 
renal replacement therapy (RRT) in patients who were 
often haemodynamically unstable and therefore unable 
to tolerate intermittent modalities of dialysis. As a result, 
CRRT has become the dialysis modality of choice for 
the treatment of AKI in critically ill adult patients with 
haemodynamic instability [2]. 
CRRT-requiring AKI in critically ill adult patients frequently 
occurs in the ICU, and is associated with high morbidity 
and mortality [3]. AKI is characterised by a rapid decline 
in kidney function and is signalled by a rising serum 
creatinine concentration and/or a reduction in urine 
output [4]. AKI has been reported to occur in up to 25% 
of ICU patients, depending on the definition, with ~6% 
requiring RRT [5-7]. The mortality rate of patients with 
multiple organ failure in the ICU approaches 50%, and 
40
increases to 80% when RRT is required [8,9]. The pre-
dominant cause of AKI in critically ill patients is acute tubular 
necrosis (ATN), usually resulting from sepsis [10]. This may 
result in life-threatening complications such as uraemia, 
volume overload, metabolic acidosis and hyperkalaemia 
that may require management with RRT.
RRT options in the ICU include intermittent haemodialysis 
(IHD), sustained low-efficiency daily dialysis (SLEDD), acute 
peritoneal dialysis and CRRT. The main difference between 
the intermittent and continuous forms of RRT is the 
duration; CRRT is delivered for 24 hours per day whereas 
IHD is usually given in 4-hour sessions. During CRRT, 
techniques that achieve solute clearance predominantly by 
convection require large volumes of ultrafiltration. A sub-
stantial amount of replacement fluid, given either by pre-
dilution or post-dilution relative to the dialyzer, is therefore 
required to maintain haemodynamic stability. Whereas 
CRRT may be preferred in haemodynamically unstable 
patients, a landmark randomised controlled trial (RCT) 
reported no difference in renal recovery, duration of RRT 
or mortality among patients receiving CRRT or IHD [11]. 
In a study conducted at a tertiary hospital in South Africa, 
the reported ICU mortality for medical patients with AKI 
was as high as 47.8% [12]. 
Lameire et al. [13] have pointed out that the incidence of 
AKI across the world is unknown due to under-reporting 
and regional disparities. Abraham et al. [14] reported a 
number of differences regarding the epidemiology of AKI 
in developing countries as compared to developed ones. 
In developed countries AKI commonly occurred in the 
elderly and was often due to nephrotoxic drug exposure 
whereas in developing countries AKI occurred at any age 
and was often due to infectious diseases such as malaria 
and diarrhoeal disease, often in the context of HIV infection. 
The incidence of CRRT-requiring AKI in developing 
countries may therefore be different from that reported by 
those in the developed world. Additional factors that may 
affect this include differences in clinical practice due to 
resource constraints. For example, patients with a very 
poor prognosis may not be admitted to the ICU and so 
may not receive RRT.
Since there is a paucity of epidemiologic data regarding 
CRRT-requiring AKI in sub-Saharan Africa, we conducted a 
study to determine the incidence of critically ill patients 
with CRRT-requiring AKI in the ICU and report here on 
their mortality rate and rate of renal recovery. 
MEtHODs
This was a single-centre, retrospective cohort study 
describing the outcomes of critically ill adult patients who 
had CRRT-requiring AKI at Universitas Academic Hospital 
(UAH) in Bloemfontein, in the Free State province of South 
Africa. 
Data were extracted from the charts of all adult patients 
≥18 years old who were admitted to one of five ICUs at 
UAH and who had CRRT-requiring AKI during the period 
1 July 2010 to 30 June 2014. UAH is the only public sector 
tertiary hospital in the Free State and operates five ICUs 
for adults with a total of 36 medical and surgical beds. 
Patients who received treatment for poisoning, treatment 
of AKI with other dialysis modalities and those with acute-
on-chronic kidney disease were excluded. Chronic kidney 
disease (CKD) was defined by an estimated glomerular 
filtration rate of <60 mL/min/1.73 m2 for more than 3 
months and/or radiographic evidence suggesting CKD 
(mainly small kidneys on ultrasound scanning). An attending 
nephrologist selected the dialysis modality and supervised 
the prescription of CRRT.
Data extracted included age, sex, comorbid diseases, 
reason for admission to the ICU and the indication for RRT. 
Additional clinical data included surgical status, number of 
organ failures and APACHE II (Acute Physiology and 
Chronic Health Evaluation II) score, duration of CRRT, 
need for mechanical ventilation and assessment of survival 
and renal recovery up to 90 days after discharge from the 
ICU. Laboratory and physiological data included serum pH, 
serum potassium, serum urea and creatinine, daily urine 
output and haemodynamic status including mean arterial 
pressure (MAP) and pulse rate. Patients were regarded as 
haemodynamically unstable when MAP was ≤65 mmHg 
and/or they required vasopressor support. 
Assessments of renal recovery and of mortality were made 
for the ICU stay, the post-ICU in-hospital stay, and for 
days 28 and 90. Patients who had improved to become 
independent of dialysis were considered to have recovered 
renal function.
statistical analysis
Descriptive data were expressed as mean ± standard 
deviation, or median and interquartile range where data 
were not distributed normally. Chi-squared and Fisher’s 
exact tests were used to compare categorical variables 
whereas the Wilcoxon rank-sum test was used to compare 
continuous variables between HIV-infected and -uninfected 
patients. Univariate and multivariate stepwise logistic 
regression was used to examine predictors of mortality. 
Statistical significance was set at P < 0.05. The data analysis 
was performed using STATA version 13.1. 
Ethics approval
Permission to conduct this study was granted by the 
Research Ethics Committee of the Faculty of Health 
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Sciences at the University of the Free State (reference 
number 230408-011) as well as by the management of 
UAH.
rEsULts
A total of 7709 adult ICU admissions were recorded over 
the 4-year period of the study, of whom 87 had CRRT-
requiring AKI, an incidence of 1.1%, or 11 per 1000 ICU 
admissions. Of these, 37 (43%) were HIV infected. Forty-
eight (55%) were female. The median age was 56 years 
(IQR 41–67 years) with the HIV-infected patients being 
significantly younger (43 versus 64 years, P < 0.01). More 
than three-quarters were Black (67, 77%), of whom the 
majority (89%) were HIV-positive. See Table 1.
The most common pre-existing non-communicable diseases 
(NCDs) were hypertension (40%), diabetes mellitus (36%) 
and heart disease (33%). Liver disease and chronic obstruc-
tive pulmonary disease were present in 24% and 17%, 
respectively. These NCDs were found predominantly in 
the HIV-uninfected group. Most patients were from the 
medical ICU (53 patients, 26 HIV-infected) with the 
remainder being from the surgical ICU (34 patients, 11 
HIV-infected). All the patients had community-acquired 
AKI. The most common causes of AKI included septic ATN 
(64%), followed by ischaemic ATN (35%) and nephrotoxic 
ATN (10%). These causes were not mutually exclusive and 
often more than one cause was present in a single patient.
The distribution of indications for the initiation of RRT is 
shown in Table 2. Sixty-nine patients (79%) were mechan-
table 1. Baseline characteristics of included participants.
Demographic All HIV+ HIV- P-value
Totals, n (%) 87 100 37 42.5 50 57.5 -
Age (years) 56 41–67 43 30–55 64 56–71 <0.01
Female, n (% of total) 48 55.2 23 62.1 25 50.0 0.26
Race, n (% of total)
White 20 23.0 4 10.8 16 32.0 0.02
Black 67 77.0 33 89.2 34 68.0
Comorbid diseases, n (% of total)
Heart disease 29 33.3 7 18.9 22 44.0 0.01
Diabetes mellitus 31 35.6 11 29.7 20 40.0 0.93
Hypertension 35 40.2 11 29.7 24 48.0 0.09
Liver disease 21 24.1 8 21.6 13 26.0 0.64
COPD 15 17.2 2 5.4 13 26.0 0.01
Distribution of ICU admissions,  
n (% of total)
Medical* 53 60.9 26 70.3 27 54.0 0.12
Surgical# 34 39.1 11 29.7 23 46.0
Disease severity, vasopressor dependence 
& laboratory parameters
Mechanical ventilation, n (% of total) 69 79.3 29 78.4 40 80.0 0.85
APACHE II score$ 28 23–30 28 23–30 29 24–31 0.13
Oliguria, n (% of total) 60 69.0 21 56.8 39 78.0 0.03
Metabolic acidosis 7.20 7.12–7.30 7.24 7.18–7.31 7.19 7.11–7.27 0.11
Vasopressor dependence prior to CRRT, n 
(% of total) 
40 46.0 18 48.6 22 44.0 0.67
Creatinine at CRRT initiation, µmol/L 362 267–450 340 272–423 387 267–463 0.45
Values expressed in a range refer to interquartile ranges; single values refer to percentage of the total population. COPD, chronic obstructive pulmonary disease; HIV, human 
immunodeficiency virus; ICU, intensive care unit; APACHE II score, Acute Physiology and Chronic Health Evaluation II score; CRRT, continuous renal replacement therapy. *Includes 
the coronary care unit, #Includes neurosurgery and cardiothoracic ICU, $Possible scores range from 0–71.
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ically ventilated. The median APACHE II score was 28 (IQR 
23–30). Sixty (69%) had oliguria and 40 (46%) had 
vasopressor dependence prior to CRRT initiation. 
The median serum creatinine at CRRT initiation was 362 
µmol/L (IQR 267–450 µmol/L). The median duration of 
CRRT was 3 days (IQR 2–4 days). The modality of CRRT 
in most patients (89%) was continuous venovenous haemo-
diafiltration (CVVHDF), with an average blood flow rate of 
120 mL/min and a dialysate flow rate of 1000 mL/hour. The 
rest were treated with continuous venovenous haemo-
dialysis (CVVHD). Anticoagulation was provided with 
unfractionated heparin to 65 patients (75%). This was the 
only anticoagulation available. The rest did not receive anti-
coagulation due to the risk of bleeding. Replacement fluid 
was administered pre-dilution to all patients, irrespective of 
bleeding risk, using normal saline at a rate of 200 mL/hour 
to reduce the risk of clotting of the dialyzer. 
Death was the outcome in 27 patients (31%). The overall 
mortality rates in the HIV-infected and -uninfected groups 
were 60% and 10%, respectively (P < 0.01). The ICU mor-
tality was higher in the HIV-infected group (43% vs. 6%, 
P < 0.01). Three patient deaths (11%) occurred post-ICU 
while in hospital and the remaining five (19%) after hospital 
discharge. Multivariate logistic regression identified female 
sex and HIV as independent predictors of mortality (see 
Tables 3 and 4). The ICU in which the patient was managed 
(medical/surgical) was not predictive of mortality. Of the 
53 patients admitted to the medical ICU, all 14 deaths 
occurred in HIV-infected patients. Of the 34 patients 
admitted to the surgical ICU, 13 deaths occurred, 8 of 
which occurred in HIV-infected patients. 
Overall, renal recovery occurred in 23 patients (26%), with 
no significant difference by status of HIV infection. Ten 
patients (44%) had renal recovery during their hospital stay, 
seven (30%) recovered by day 28 and six more (26%) by 
day 90. The median serum creatinine concentration at the 
end of the study period for those who recovered kidney 
function was 130 µmol/L (IQR 125–130), with a median 
value of 127.5 µmol/L (IQR 118–130) in the HIV-infected 
group and 135 µmol/L (IQR 125–130) in the HIV-
uninfected group (P = 0.25).
table 2. Indications for the initiation of renal  
replacement therapy.
Indications for RRT# n (% of total)
Metabolic acidosis (pH < 7.2) 72 (82.6)





RRT, renal replacement therapy. *Acute cognitive impairment, altered level of con-
sciousness or seizures, upper gastro-intestinal bleeding with gastritis and pericar-
ditis that was not otherwise explained. # More than one indication was present 
in most patients.
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table 3. Summary of outcomes.
Primary outcome All patients HIV+ HIV- P-value
n % of total n % of group n % of group
Patients with CRRT-requiring AKI 87 100 37 42.5 50 57.5 -
Overall mortality 27 31.0 22 59.5 5 10.0 <0.01
ICU 19 21.8 16 43.2 3 6.0 <0.01
In-hospital 3 3.4 2 5.4 1 2.0 0.55
Post-discharge 5 5.7 4 10.8 1 2.0 0.03
Overall renal recovery 23 26.4 7 18.9 16 32.0 0.17
ICU 10 11.5 2 5.4 8 16.0 0.18
Day 28 7 8.0 3 8.1 4 8.0 1.00
Day 90 6 6.9 2 5.4 4 8.0 0.69
Creatinine at end of study, µmol/L 130 125–140 127.5 118–130 135 125–140 0.25
Duration of CRRT, days 3.0 2-4 3.0 2-4 3.0 2-4 0.37
Values expressed in a range refer to interquartile ranges; single values refer to percentages. HIV, human immunodeficiency virus; ICU, intensive care unit; CRRT-requiring AKI, 
continuous renal replacement therapy-requiring acute kidney injury. 
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DIscUssION
The incidence for CRRT-requiring AKI over the 4 years of 
the study was 1.1%, or 11 per 1000 ICU patients. This rate 
is relatively very low when compared to results in devel-
oped countries, where 80% of all ICU patients with AKI 
receive CRRT as the treatment modality [14]. In a multi-
centre study of more than 29 000 critically ill patients, 
5.7% developed AKI during their stay in ICU of whom 
~70% required RRT [9]. Another study reported that 
37.2% of 500 critically ill patients required RRT [15]. A 
study from South India reported that a total of 69% of 
1112 patients with AKI required RRT with the majority 
receiving IHD [16]. A study from Nigeria reported that 
51% of 212 cases of AKI required RRT. All received IHD as 
the dialysis modality [17]. The latter two studies included all 
hospitalised patients with RRT requiring AKI. In a study 
reporting outcomes of critically ill HIV patients with AKI, 
15% required CRRT [18]. The primary reason for the low 
incidence of CRRT at our institution is predominantly 
related to the high costs involved when using this modality. 
Also, many critically ill patients who have AKI will not be 
admitted to the ICU because the overall prognosis is 
thought to be poor. Thus, patients who may potentially 
benefit from CRRT will not receive it. However, it should 
be noted that the current study excluded patients who 
received other modalities of dialysis and was limited to ICU 
patients only. 
The overall mortality of 31.0% is high but is much lower 
than that reported by others. A study conducted on 
medical ICU patients at Tygerberg Hospital in Cape Town, 
South Africa found that 17% of 46 patients with AKI 
required dialysis [12]. However, only 2 patients received 
CRRT. Other studies have reported mortality rates that 
range from 47–74% [2,19-21]. The median age of our 
cohort was 56 years, which was similar to that reported by 
others [2,19-21]. However, our HIV-infected group had a 
median age of 43 years. Despite their younger age, similar 
APACHE II scores and fewer comorbid NCDs, the 
mortality of those infected with HIV was relatively very high 
when compared to the uninfected group (60% vs. 10%, 
P < 0.01). HIV infection and female sex were identified as 
independent predictors of mortality. South Africa has the 
largest antiretroviral rollout programme in the world [22] 
but many patients are still unable to gain access to this life-
saving treatment and present with AIDS-defining illnesses, 
which may explain the high mortality in this group. It is 
unclear why female sex was associated with mortality.
Most patients received CVVHDF, with an average blood 
flow rate of 120 mL/min and a dialysate flow rate of 1 000 
mL/hour. A shortcoming of this study was that the effluent 
flow rate (EFR) was not recorded. Outcomes of critically ill 
patients have been linked to the dose of CRRT prescribed. 
In two large RCTs, critically ill patients were randomised 
to either low-intensity RRT with EFRs that ranged from 
20–25 mL/kg/hour or higher intensity RRT with EFRs of 
35–40 mL/kg/hour [11, 23]. The primary outcome, death, 
was no different in the two arms of these studies. It should 
be noted that the EFRs in the low-intensity arms of both 
RCTs were much higher than that achieved in usual clinical 
practice. An often-overlooked modality of CRRT in the 
ICU is peritoneal dialysis (PD). A study conducted in Brazil 
reported effective treatment of critically ill patients with 
AKI using high-volume PD [24]. In countries where con-
temporary modalities of CRRT are not available, high-
volume PD may be a good alternative. 
The median duration of CRRT was only 3 days. The inter-
ruption of treatment for radiological imaging or surgical 
procedures and for the replacement of clotted dialyzers 
may have had an effect on the delivered dose of RRT, and 
this may have affected outcomes [25]. 
Renal recovery occurred in only 26.4%. Despite being 
independent of dialysis, many had incomplete renal 
recovery at the time of last follow-up. It is possible that 
some may have had underlying CKD as many had NCDs 
such as diabetes and hypertension. It is also possible that 
AKI had resulted in CKD [26]. Regardless of such issues, the 
results are of concern, as many patients still remained 
dialysis-dependent. In the public healthcare sector of South 
Africa, due to resource constraints and rationing of RRT, 
many of these patients may not be accommodated on 
chronic RRT programmes [27].
Our study has some limitations. It was a relatively small, 
single-centre, retrospective investigation and therefore 
confounding and missing data may have affected the 
results. However, its strengths include the interesting 
comparisons of the outcomes between the HIV-infected 
and -uninfected groups.
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table 4. Univariate and multivariate logistic regression 
analysis for predictors of mortality.
Univariate analysis Odds ratio P-value
Female sex 4.2 < 0.01
HIV infected 13.2 < 0.01
Multivariate analysis
Female sex 4.9 0.01
HIV infected 14.4 < 0.01
HIV, human immunodeficiency virus.
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cONcLUsION
The incidence of CRRT-requiring AKI in critically ill adult 
patients at UAH was very low and we had a relatively low 
overall mortality when compared to the rates reported by 
others. However, the mortality of the HIV-infected patients 
was very high. The low rates of renal recovery in those who 
survived adds to the numbers of patients requiring chronic 
RRT and increases the financial burden in a country with an 
already-constrained healthcare budget.
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